| Recruiting | Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Me NCT06957691 | Shehzad Basaria, M.D. | Phase 2 |
| Not Yet Recruiting | Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Character NCT07238959 | Shanghai Changzheng Hospital | — |
| Recruiting | A Study of LY4257496 in Participants With Cancer (OMNIRAY) NCT07114601 | Eli Lilly and Company | Phase 1 |
| Not Yet Recruiting | Robotic Prostatectomy Artificial Intelligence Low Pressure Pain (RALP) Trial NCT06915909 | East and North Hertfordshire NHS Trust | N/A |
| Recruiting | Impact of Using the Airseal System With Ultra-low Pneumoperitoneum in Patients Undergoing Robot-assisted Radic NCT06784986 | Brazilian Institute of Robotic Surgery | Phase 4 |
| Recruiting | Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer Care NCT06630962 | Northwestern University | N/A |
| Not Yet Recruiting | Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Stu NCT06430411 | Medical University of Vienna | — |
| Recruiting | Effectiveness of Focal Therapy in Men With Prostate Cancer NCT06223295 | Radboud University Medical Center | N/A |
| Unknown | Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient NCT05422105 | Primo Biotechnology Co., Ltd | — |
| Recruiting | MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy NCT05710380 | University of Chicago | N/A |
| Recruiting | Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progr NCT06292897 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | — |
| Unknown | Protein Kinase A in Prostate Cancer Tissue. NCT05460312 | Ziv Hospital | — |
| Terminated | Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose. NCT05276492 | University of Chicago | Phase 1 |
| Not Yet Recruiting | Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptiv NCT05373316 | Radboud University Medical Center | Phase 2 |
| Withdrawn | Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC NCT05191017 | Nuvation Bio Inc. | Phase 1 / Phase 2 |
| Terminated | NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid NCT05252390 | Nuvation Bio Inc. | Phase 1 |
| Completed | Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed Cognitive Fusion TRUS Guided NCT05137561 | Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 2 / Phase 3 |
| Completed | Strength, Aging, and Memory in Prostate Cancer NCT04852224 | University of Nebraska | — |
| Active Not Recruiting | Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy NCT04053842 | Glenn Bauman | Phase 2 |
| Terminated | Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors NCT04541225 | Nuvation Bio Inc. | Phase 1 |
| Unknown | Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis. NCT04792138 | University College, London | — |
| Completed | The Robot-Assisted Laparoscopic Radical Prostatectomy Combined Anterior and Posterior Approach NCT06020287 | Nanjing University School of Medicine | — |
| Active Not Recruiting | Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0 NCT04045717 | Universitaire Ziekenhuizen KU Leuven | Phase 2 |
| Unknown | Unfavorable MRI But Favorable 68Ga-PSMA PET/MRI for Primary Prostate Cancer Detection NCT04124107 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | N/A |
| Active Not Recruiting | Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer NCT04030338 | Memorial Sloan Kettering Cancer Center | — |
| Completed | A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer NCT04019327 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Recruiting | MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer De NCT03819751 | Universitaire Ziekenhuizen KU Leuven | N/A |
| Recruiting | The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study NCT04075305 | UMC Utrecht | — |
| Completed | Prostate Cancer Screening Trial Using Imaging NCT03702439 | Imperial College London | — |
| Unknown | Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer Detection NCT03572946 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | N/A |
| Active Not Recruiting | CyberKnife Dose Escalation Prostate Cancer Trial NCT03822494 | Crozer-Keystone Health System | N/A |
| Completed | Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer NCT03828838 | Radboud University Medical Center | Phase 1 / Phase 2 |
| Completed | A Prospective Study Of Free-Hand Transperineal Image Fusion Targeted Biopsies Under Local Anesthesia NCT04376008 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | N/A |
| Completed | Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) NCT03493945 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Recruiting | Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy NCT03424850 | Washington University School of Medicine | Phase 1 / Phase 2 |
| Completed | Pre-Operative Single Shot Rectus Sheath Block NCT03458598 | University of Alberta | N/A |
| Unknown | Early and Accurate Detection of Prostate Cancer in General Practice NCT03431753 | Aarhus University Hospital | N/A |
| Suspended | Capture of Prostatic Trans-rectal Ultrasound Scans for Research NCT03321864 | Cambridge University Hospitals NHS Foundation Trust | N/A |
| Completed | Health Gatherings - For Your Health After Cancer NCT03344757 | University of Miami | N/A |
| Completed | PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer NCT03232164 | University of Wisconsin, Madison | EARLY_Phase 1 |
| Terminated | 18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancer NCT02809690 | University of Southern California | Phase 1 |
| Active Not Recruiting | COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate Cancer NCT03241537 | Samsung Medical Center | Phase 3 |
| Completed | PRostate Evaluation for Clinically Important Disease: Sampling Using Image-guidance Or Not? NCT02380027 | University College, London | Phase 3 |
| Recruiting | Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI NCT06315595 | Mayo Clinic | — |
| Completed | Reducing Sedentary Behavior Among Prostate Cancer Survivors on Androgen Deprivation Therapy NCT03321149 | University of Illinois at Urbana-Champaign | N/A |
| Unknown | Efficacy of Extracorporeal Biofeedback Device for Post-prostatectomy Incontinence NCT02485665 | Seoul National University Hospital | N/A |
| Unknown | Impact of Preoperative HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prost NCT02436122 | Seoul National University Hospital | — |
| Completed | Addressing Prostate Cancer Information Disparities With eHealth Technology NCT02787434 | Tufts University | N/A |
| Unknown | Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to NCT01630967 | British Columbia Cancer Agency | Phase 2 |
| Completed | F-18 Sodium Fluoride in Prostate Cancer NCT01240551 | National Cancer Institute (NCI) | Phase 2 |
| Completed | MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer Followed by Radical Prostatectomy NCT00805883 | University Health Network, Toronto | Phase 1 |
| Unknown | A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors NCT02225262 | Community Cancer Center, Normal, Illinois | N/A |
| Completed | Role of Soy Supplementation in Prostate Cancer Development NCT00255125 | VA Office of Research and Development | Phase 3 |
| Completed | PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer NCT00005916 | National Cancer Institute (NCI) | Phase 2 |